1. Home
  2. STTK vs ITRG Comparison

STTK vs ITRG Comparison

Compare STTK & ITRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shattuck Labs Inc.

STTK

Shattuck Labs Inc.

HOLD

Current Price

$4.18

Market Cap

538.3M

Sector

Health Care

ML Signal

HOLD

Logo Integra Resources Corp.

ITRG

Integra Resources Corp.

HOLD

Current Price

$2.45

Market Cap

572.1M

ML Signal

HOLD

Company Overview

Basic Information
Metric
STTK
ITRG
Founded
2016
1997
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Precious Metals
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
538.3M
572.1M
IPO Year
2020
2017

Fundamental Metrics

Financial Performance
Metric
STTK
ITRG
Price
$4.18
$2.45
Analyst Decision
Buy
Strong Buy
Analyst Count
7
2
Target Price
$10.00
$5.13
AVG Volume (30 Days)
860.8K
2.8M
Earning Date
05-01-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
53.02
N/A
EPS
N/A
N/A
Revenue
$1,000,000.00
N/A
Revenue This Year
N/A
$67.34
Revenue Next Year
N/A
$25.89
P/E Ratio
N/A
$45.07
Revenue Growth
N/A
N/A
52 Week Low
$0.71
$1.43
52 Week High
$8.33
$4.87

Technical Indicators

Market Signals
Indicator
STTK
ITRG
Relative Strength Index (RSI) 28.36 42.26
Support Level $3.67 N/A
Resistance Level $4.23 $3.29
Average True Range (ATR) 0.51 0.14
MACD -0.15 -0.01
Stochastic Oscillator 27.29 29.63

Price Performance

Historical Comparison
STTK
ITRG

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

About ITRG Integra Resources Corp.

Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of prospective early-stage exploration projects in Idaho, Nevada, and Arizona.

Share on Social Networks: